SCHEMBL29323224

SCHEMBL29323224

C[C@@H](COCCNC(=O)OCc1ccccc1)CN1C(=O)c2ccccc2C1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
L3MBTL1 Q9Y468 2/20 0.50
MAPK1 P28482 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
RAB9A P51151 1/20 0.50
MAPT P10636 1/20 0.47
HTT P42858 1/20 0.44
TPSAB1 Q15661 5/20 0.44
TPSD1 Q9BZJ3 5/20 0.44
TPSG1 Q9NRR2 5/20 0.44
ELANE P08246 2/20 0.44
PRSS1 P07477 1/20 0.44
PRSS2 P07478 1/20 0.44
PRSS3 P35030 1/20 0.44
KCNA5 P22460 1/20 0.42
PLG P00747 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18085395 0.87 CYP3A4 (0.53) LMNASMN1; SMN2L3MBTL1MAPK1CYP3A4
SCHEMBL31072561 0.86 LMNA (0.57) LMNASMN1; SMN2L3MBTL1MAPK1CYP3A4
SCHEMBL29323153 0.83 MALT1 (0.47) LMNAMAPK1TPSAB1TPSD1TPSG1
SCHEMBL29262775 0.82 LMNA (0.71) LMNASMN1; SMN2L3MBTL1CYP3A4CYP2D6
SCHEMBL29323231 0.82 SMN1; SMN2 (0.70) LMNASMN1; SMN2L3MBTL1MAPTHTT
SCHEMBL29323035 0.81 SMN1; SMN2 (0.68) LMNASMN1; SMN2L3MBTL1MAPTHTT
SCHEMBL19016323 0.81 SMN1; SMN2 (0.68) LMNASMN1; SMN2L3MBTL1MAPTHTT
SCHEMBL31072520 0.81 SYK (0.55) LMNASMN1; SMN2L3MBTL1MAPK1CYP3A4
SCHEMBL2564693 0.78 LMNA (0.64) LMNASMN1; SMN2L3MBTL1HTTTPSAB1
SCHEMBL22151127 0.77 RAB9A (0.64) MAPK1CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239771-A1 BACTERIAL EFFLUX PUMP INHIBITORS TAXIS PHARMACEUTICALS, INC. 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239771-A1 BACTERIAL EFFLUX PUMP INHIBITORS ABCB11, ABCB1, SLC47A1 LMNA 3705/4885SMN1; SMN2 4880/4885L3MBTL1 4688/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.